Abstract
Purpose
Toxoplasma gondii is an important opportunistic intracellular protozoan parasite that can cause severe sequelae and even death in immunodeficient patients. This study aimed to evaluate the seroprevalence and risk factors of toxoplasmosis among HIV+/AIDS patients of the study area.
Methods
A cross-sectional study was carried out on 121 registered HIV+/AIDS patients of behavioral diseases consultation center (BDCC) in Guilan province, north of Iran. Anti-Toxoplasma IgG and IgM antibodies were measured by ELISA technique in the serum samples. IgG avidity was measured for IgG- plus IgM-positive cases. Also, the relationship between T. gondii infection and related demographic and clinical characteristics were investigated.
Results
Anti-T. gondii IgG and IgM antibodies were detected in 60.3 and 4.9% of patients, respectively. One case of acute toxoplasmosis (0.83%) was detected using an IgG avidity test. A significant correlation was observed between toxoplasmosis with age and marital status in these patients. The mean CD4+count of HIV+/AIDS patients was 549 ± 27 cells/µl. Viral load in 69.7% of the HIV patients was less than1000 copies/ml.
Conclusion
None of the T. gondii IgM-positive HIV patients received anti-Toxoplasma prophylaxis. This finding highlights the importance of T. gondii infection surveillance in HIV patients. Regarding the high prevalence of toxoplasmosis in the study population, educational efforts are recommended to prevent reactivation or acquiring primary infection and developing severe cases of toxoplasmosis in immunocompromised HIV+/AIDS patients.
Similar content being viewed by others
References
Wang Z-D, Wang S-C, Liu H-H, Ma H-Y, Li Z-Y, Wei F et al (2017) Prevalence and burden of Toxoplasma gondii infection in HIV-infected people: a systematic review and meta-analysis. Lancet HIV 4(4):e177–e188. https://doi.org/10.1016/S2352-3018(17)30005-X
Ayoade F, Joel Chandranesan AS (2020 Jan) HIV-1 Associated toxoplasmosis. [updated 2020 Sep 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/books/NBK441877/. Access Dec 2020
Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ et al (2015) Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. lancet HIV 2(10):e438–e444. https://doi.org/10.1016/S2352-3018(15)00137-X
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommendations and reports: Morbidity and mortality weekly report recommendations and reports 58(Rr-4):1-207; quiz CE1-4. PMID: 19357635. Clin Infect Dis. https://doi.org/10.1093/cid/ciu094
Gagliuso DJ, Teich SA, Friedman AH, Orellana J (1990) Ocular toxoplasmosis in AIDS patients. Trans Am Ophthalmol Soc 88:63–86
Abdollahi A, Heidari-Bateni G, Zarei R, Kheirandish P, Malekmadani M, Mohraz M et al (2010) Clinical spectrum of 15 patients with HIV-related ocular involvement in Tehran. Int J Ophthalmol 3(4):331. https://doi.org/10.3980/j.issn.2222-3959.2010.04.13
Montoya JG, Boothroyd JC, Joseph AK (2010) Toxoplasma gondii. In: Gerald LM, John EBRD (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 7th edn. Churchill Livingstone, Philadelphia, pp 3495–3526
Remington JS, McLeod R, Wilson CB, Desmonts G (2011) Toxoplasmosis. In: Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA (eds) Infectious diseases of the fetus and newborn infant, 7th edn. Saunders, Philadelphia, pp 918–1041
Rosso F, Les JT, Agudelo A, Villalobos C, Chaves JA, Tunubala GA et al (2008) Prevalence of infection with Toxoplasma gondii among pregnant women in Cali, Colombia, South America. Am J Trop Med Hyg 78(3):504–508. https://doi.org/10.4269/ajtmh.2008.78.504
Ahmadpour E, Daryani A, Sharif M, Sarvi S, Aarabi M, Mizani A et al (2014) Toxoplasmosis in immunocompromised patients in Iran: a systematic review and meta-analysis. J Infect Dev Ctries 8(12):1503–1510. https://doi.org/10.3855/jidc.4796
UNAIDS. The gap report 2014. Geneva, Switzerland, UNAIDS. 2014. Available at: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf. Accessed Feb 2020
Ghorbani M, Edrissian GH, Assad N (1978) Serological survey of toxoplasmosis in the northern part of Iran, using indirect fluorescent antibody technique. Trans R Soc Trop Med Hyg 72(4):369–371. https://doi.org/10.1016/0035-9203(78)90129-3
Daryani A, Sarvi S, Aarabi M, Mizani A, Ahmadpour E, Shokri A et al (2014) Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta trop 137:185–194. https://doi.org/10.1016/j.actatropica.2014.05.015
Bavand A, Aghakhani A, Mohraz M, Banifazl M, Karami A, Golkar M et al (2019) Prevalence of Toxoplasma gondii antibodies and DNA in Iranian HIV patients. Iran J Pathol 14(1):68–75. https://doi.org/10.30699/IJP.14.1.68
Rahimi MT, Mahdavi SA, Javadian B, Rezaei R, Moosazadeh M, Khademlou M et al (2015) High seroprevalence of Toxoplasma gondii antibody in HIV/AIDS individuals from north of Iran. Iran J Parasitol 10(4):584–589
Daryani A, Sharif M, Meigouni M (2011) Seroprevalence of IgG and IgM anti-Toxoplasma antibodies in HIV/AIDS patients, northern Iran. Asian Pac J Trop Biomed 4(4):271–274. https://doi.org/10.1016/S1995-7645(11)60084-9
Hoshina T, Horino T, Saiki E, Aonuma H, Sawaki K, Miyajima M et al (2020) Seroprevalence and associated factors of Toxoplasma gondii among HIV-infected patients in Tokyo: a cross sectional study. J Infect Chemother 26:33–37. https://doi.org/10.1016/j.jiac.2019.06.012
Shen G, Wang X, Sun H, Gao Y (2016) Seroprevalence of Toxoplasma gondii infection among HIV/AIDS patients in eastern China. Korean J Parasitol 54(1):93–96. https://doi.org/10.3347/kjp.2016.54.1.93
Feleke DG, Gebreweld A, Zewde G (2019) Toxoplasmosis in pregnant women and HIV/AIDS patients in Ethiopia: a systematic review and meta-analysis. J Parasitol Res 2019:4670397. https://doi.org/10.1155/2019/4670397
Nazari N, Bozorgomid A, Janbakhsh A, Bashiri F (2018) Toxoplasma gondii and human immunodeficiency virus co-infection in western Iran: a cross sectional study. Asian Pac J Trop Med 11(1):58–62. https://doi.org/10.4103/1995-7645.223562
Zhang Y-B, Cong W, Li Z-T, Bi X-G, Xian Y, Wang Y-H et al (2015) Seroprevalence of Toxoplasma gondii infection in patients of intensive care unit in China: a hospital based study. Biomed Res Int. https://doi.org/10.1155/2015/908217
Walle F, Kebede N, Tsegaye A, Kassa T (2013) Seroprevalence and risk factors for toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar. Northwest Ethiopia Parasit Vectors 6:15. https://doi.org/10.1186/1756-3305-6-15
Flegr J, Klapilová K, Kaňková Š (2014) Toxoplasmosis can be a sexually transmitted infection with serious clinical consequences. Not all routes of infection are created equal. Med hypotheses 83(3):286–289. https://doi.org/10.1016/j.mehy.2014.05.019
Alvarado-Esquivel C, Sánchez-Anguiano LF, Hernández-Tinoco J, Arreola-Cháidez E, López J, Salcido-Meraz KI et al (2015) High seroprevalence of Toxoplasma gondii infection in female sex workers: a case-control study. Eur J Microbiol Immunol 5(4):285–292. https://doi.org/10.1556/1886.2015.00039
Pastorello RG, Costa AdCL, Sawamura MVY, Nicodemo AC, Duarte-Neto AN (2018) Disseminated toxoplasmosis in a patient with advanced acquired immunodeficiency syndrome. Autops Case Rep. https://doi.org/10.4322/acr.2018.012
Rezanezhad H, Sayadi F, Shadmand E, Nasab SD, Yazdi HR, Solhjoo K et al (2017) Seroprevalence of Toxoplasma gondii among HIV patients in Jahrom, Southern Iran. Korean J Parasitol 55(1):99–103. https://doi.org/10.3347/kjp.2017.55.1.99
Yenilmez E, Çetinkaya RA (2019) Difference in Toxoplasma gondii seroprevalence rates due to low and high CD4 counts in patients with HIV/AIDS. Turkiye Parazitol Derg. https://doi.org/10.4274/tpd.galenos.2019.6457
WHO. What’s new in treatment monitoring: viral load and cd4 testing. Update. 2017. Available at: https://apps.who.int/iris/bitstream/handle/10665/255891/WHO-HIV-2017.22-eng.pdf?sequence=1. Accessed Feb 2020
Fernandes MA, Batista GI, Carlos Jda C, Gomes IM, Azevedo KM, Setúbal S et al (2012) Toxoplasma gondii antibody profile in HIV-1-infected and uninfected pregnant women and the impact on congenital toxoplasmosis diagnosis in Rio de Janeiro. Brazil Braz J Infect Dis 16(2):170–1174. https://doi.org/10.1590/S1413-86702012000200011
Ngobeni R, Samie A, Ngobeni R, Samie A (2017) Prevalence of Toxoplasma gondii IgG and IgM and associated risk factors among HIV-positive and HIV-negative patients in Vhembe district of South Africa. Afr J Infect Dis 11(2):1–9. https://doi.org/10.21010/ajid.v11i2.1
Mohraz M, Mehrkhani F, Jam S, SeyedAlinaghi SA, Sabzvari D, Fattahi F et al (2011) Seroprevalence of toxoplasmosis in HIV+/AIDS patients in Iran. Acta Med Iran 49(4):213–218
Acknowledgements
The authors would like to thank the Behavioral Diseases Consultation Center (BDCC) of Guilan, Iran and all participants for their kind assistance during this study. We appreciate the Guilan University of Medical Sciences for the financial support (Grant No. 96112111).
Author information
Authors and Affiliations
Contributions
HRS–HJS: literature search, data acquisition, data analysis, experimental studies, manuscript preparation, and manuscript review. BMS–BMS: concept, design, definition of intellectual content, experimental studies, data analysis, manuscript preparation, manuscript editing, manuscript review, and supervision of all research steps. RJS–RJS: concept, definition of intellectual content, experimental studies, manuscript editing, and manuscript review. MRM–MRM: design, data analysis, manuscript editing, and manuscript review. ZAR–ZAR: design, statistical analysis, data analysis, definition of intellectual content, and manuscript review. SMR–SMR: definition of intellectual content, data acquisition, experimental studies, data analysis, and manuscript review.
Corresponding author
Ethics declarations
Conflict of Interest
We have no conflict of interest related to this work.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rafati-Sajedi, H., Majidi-Shad, B., Jafari-Shakib, R. et al. Serological Evaluation of Toxoplasmosis and Related Risk Factors Among HIV+/AIDS Patients in Northern Iran. Acta Parasit. 66, 1417–1423 (2021). https://doi.org/10.1007/s11686-021-00410-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11686-021-00410-7